Indocoar Pharma Private Limited, a active private limited company, was established on 04 October 1985 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239KA1985PTC007188. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.38 Cr.
Formerly known as M Apotheke Private Limited. It upholds a compliant status. Employing 48 professional, Its leadership includes Chandrakanth Gurupadappa Mahalingashetty (Managing Director), Shetty Chandrakant Mahalingashetty Shweta (Director). Past directors included Tak Lim Kang, Kotambail Vakuda Krishna Moorthy, Vimala Chandrakanth. It holds ₹17.03 Cr open charges and ₹5.89 Cr settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at No 10, 1St Main, Amarjyothi Layout, Sanjaynagar, Bangalore, Karnataka, 560094.
U24239KA1985PTC007188
007188
04 October 1985
₹6.00 Cr
₹4.38 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Indocoar Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandrakanth Gurupadappa Mahalingashetty | Managing Director | 04 Oct 1985 | Current |
| Shetty Chandrakant Mahalingashetty Shweta | Director | 24 Jan 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 31 Jan 2018 | Past |
| Pramod Abcsdd | Director | 29 Aug 2008 | Past |
| Pramod Abcsdd | Director | 23 Jan 2018 | Past |
| Pramod Abcsdd | Director | 25 Jan 2019 | Past |
| Pramod Abcsdd | Additional Director | 31 Jan 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indocoar Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 102.56% increase. The company also saw a substantial improvement in profitability, with a 117.27% increase in profit. The company's net worth Soared by an impressive increase of 17.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Indocoar Pharma had a public holding of 54.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹170,273,000.00
₹58,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 2023 | Others | ₹7.25 M | Open |
| 21 Mar 2022 | Others | ₹1.65 M | Open |
| 02 Dec 2019 | Others | ₹15.84 Cr | Open |
| 29 May 2018 | Others | ₹3.00 M | Open |
| 28 Sep 2010 | Union Bank Of India | ₹3.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Indocoar Pharma has a workforce of 48 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Indocoar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indocoar Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Indocoar Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was completed.
Progress on Indocoar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The activity A charge with Others amounted to Rs. 0.73 Cr with Charge ID 100837436 was registered on 07 Dec 2023. was completed.
A charge with Others of Rs. 15.84 Cr registered on 02 Dec 2019 with Charge ID 100312754 was modified on 13 Jul 2022. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.17 Cr with Charge ID 100556544 was registered on 21 Mar 2022. was documented.
Progress on A charge with Others amounted to Rs. 15.84 Cr with Charge ID 100312754 was registered on 02 Dec 2019. was documented.
The CIN of Indocoar Pharma Private Limited is U24239KA1985PTC007188.
Indocoar Pharma Private Limited is headquartered at No 10, 1St Main, Amarjyothi Layout, Sanjaynagar, Bangalore, Karnataka, 560094.
Indocoar Pharma Private Limited was incorporated on 04 October 1985.
The current directors of Indocoar Pharma Private Limited are
The primary industry of Indocoar Pharma Private Limited is Manufacturing.
Indocoar Pharma Private Limited is unlisted.
The authorized capital of Indocoar Pharma Private Limited is ₹6.00 Cr, and the paid-up capital is ₹4.38 Cr.
The compliance status of Indocoar Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX